BioNTech SE (NASDAQ:BNTX)
| 195.90 Delayed Data As of Jan 14 |  -7.09 / -3.49%Today’s Change | 90.29 Today|||52-Week Range 464.00 | -24.01% Year-to-Date |
Latest BNTX News | Press Releases
| 3 Top Dividend Stocks to Buy Now Jan 16 / MotleyFool.com - Paid Partner Content | Moderna Plans March Release of Children's Vaccine Trial Data Jan 13 / GuruFocus News - Paid Partner Content |
| Is the COVID-19 Investing Boom Over? Jan 15 / MotleyFool.com - Paid Partner Content | Vaxxinity (VAXX) Starts Dosing in Parkinson's Disease Study Jan 13 / Zacks.com - Paid Partner Content |
| AstraZeneca (AZN) COVID-19 Booster Dose Useful Against Omicron Jan 14 / Zacks.com - Paid Partner Content | Ocugen's (OCGN) COVID-19 Booster Effective Against Omicron Jan 13 / Zacks.com - Paid Partner Content |
| Why Pfizer and BioNTech Got Thrashed on Thursday Jan 13 / MotleyFool.com - Paid Partner Content | Pfizer's (PFE) Prevnar 20 Plus COVID Vaccine Study Succeeds Jan 13 / Zacks.com - Paid Partner Content |
| Why Shares of BioNTech Rose 216% in 2021 Jan 13 / MotleyFool.com - Paid Partner Content | 5 Reasons Why Pfizer Is a Better Stock to Buy Right Now Than Moderna Jan 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 202.99 |
| Today’s open | 194.52 |
| Day’s range | 194.52 - 205.93 |
| Volume | 104,136 |
| Average volume (3 months) | 3,241,583 |
| Market cap | $47.5B |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +60,843.11% |
| Earnings growth (next 5 years) | +578.31% |
| Revenue growth (last year) | +352.40% |
| P/E ratio | 5.6 |
| Price/Sales | 36.85 |
| Price/Book | 28.18 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | April 5, 2022 |
| EPS forecast (this quarter) | $7.67 |
| Annual revenue (last year) | $549.8M |
| Annual profit (last year) | $17.3M |
| Net profit margin | 3.15% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
